2024 ASPHO Conference

The 2024 American Society of Pediatric Hematology/Oncology (ASPHO) Conference took place April 3-6, 2024 in Seattle, Washington, and featured education and networking events for hospitalists, physician assistants, advanced nurse practitioners, other advanced practice providers, and allied healthcare professionals.

How Can We Reduce Pediatric Cancer Treatment Abandonment in Low- and Middle-Income Regions?

A meta-analysis of 24 studies observed a decrease in pediatric cancer treatment abandonment after the intervention.

What Is the Role of Palliative Care in Pediatric Patients with Blood Cancers?

Palliative care facilitates communication and helps with symptom management, the researchers noted.

Michel Zwaan, MD, PhD: 'Clear Medical Need’ in KMT2Ar Pediatric Acute Leukemias

A phase II study presented at ASPHO 2024 evaluated revumenib in KMT2A-rearranged ALL and AML.

Shaikha AlQahtani, MD, on Cladribine in Pediatric Relapsed Leukemias

Around 45% of patients had a complete response after cladribine, and 31% proceeded to transplant.

Waitman Aumann, MD, MS, Shares Data on SIX1 Knockdown in T-ALL, AML

The researchers found that CALM-AF10 leukemia cells grow slower after the SIX1 knockdown.

Nirali Shah, MD, MHSc, Receives Frank A. Oski Memorial Lectureship at ASPHO

Dr. Shah’s areas of expertise include immunology and immunotherapy, rare tumors, CAR T-cell therapies, and transplantation.

What Is the Role of HSCT in Pediatric, Young Adult Patients With BPDCN?

The investigators reviewed case reports of patients 20 years old and younger who underwent therapy for BPDCN.

ASPHO President Caroline Hastings, MD, on Exciting ASPHO Sessions

The conference has a lot of great sessions, including an untraditional keynote speaker, Dr. Hastings said.